The 5 Coffee A Tale of Tariffs Climate Shifts and Changing Tastes
SP 500 Edges Higher as Healthcare and Tech Rally Communication Services Lags
Hindalco Reports 51 Decline in Q4 Net Profit Board Declares Rs 5 Dividend
IAMPROSAY Launches New Automated LegalTech Tools to Streamline Administrative Workflows
Micron Stock Surges as UBS Triples Price Target on AI Memory Demand
Brookings Study Examines Data Center Employment Impact on Local Economies
DocGo Q1 2026 Earnings EPS Misses Estimates but Shares Rise
CENT Q1 2026 Earnings Profitability Surprise Lifts Confidence Despite Flat Revenue Disclosure
XENE Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Continues
Resideo Technologies REZI Q1 2026 Earnings EPS Beats Estimates by 533 Stock Edges Lower
EH Q4 2025 Earnings Significant EPS Surprise Highlights Progress in eVTOL Commercialization
CRESY Q1 2026 Earnings Strong EPS Performance Despite Market Headwinds
Plum Acquisition Corp IV Warrants PLMKW Hold Steady at 060 as Trading Consolidates
Keros Therapeutics KROS Rises 196 Testing Key Resistance at 1202
Capital Bancorp Inc CBNK Holds Steady Near Key Resistance After Marginal Decline
MINISO Group MNSO Faces Headwinds as Shares Slide 15 to 1353
Incyte Corp INCY Holds Steady Near 97 as Support and Resistance Levels Define Trading Range
Paul Tudor Jones Boosts IREN Stake by 57 in Bet on AI Infrastructure Buildout
SHF Holdings Inc SHFS Q3 2024 Earnings Modest Profitability Amid Cannabis Financial Services Landscape
ENDRA Life Sciences NDRA Shows Modest Gains Testing Resistance at 573
CAC Camden Natl posts nearexpected Q4 2025 EPS shares slip 04 on mild investor caution
FBRTE Franklin quarterly earnings metrics remain undisclosed with investors awaiting full operational and financial performance updates
EQR Equity Q1 2026 EPS vastly outperforms estimates stock notches a small gain in todays trading
Morgan Stanley MS Cuts iQIYI IQ Financial Projections and Price Target Amid NearTerm Operating Headwinds
The long term thesis for Altisource ASPSZ in plain sight Investor Concern 20260506
PSECA Prospect 535 fixed rate structure delivers predictable quarterly earnings amid broad market volatility
ZURA Zura Bio posts far wider Q4 2025 loss than consensus estimates sending its shares down 254 today